Raises €13.2 million, market capitalisation €44.5 million
Paris – 10 July 2015– EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for small and medium-sized companies (SMEs),today celebrated the listing of Amoeba, a company producing a green biocide that eliminates bacterial risk in water. Amoeba is listed on the regulated market of Euronext Paris (Compartment C).
Based outside Lyon, France, in Chassieu, Amoeba produces an entirely natural biocide that eliminates risk from bacteria present in water—Legionella, Pseudomonas, Listeria and more. This biocide is an effective alternative to chemical biocide used to treat industrial water being returned to the environment. Its patented technology relies on unique expertise that uses an industrial production process based on a continuous suspension. Efficiency has been demonstrated successfully in tests at industrial sites and several businesses already use Amoeba’s biocide on an experimental basis.
Amoeba (ticker code: AMEBA) was listed through the admission to trading on 10 July 2015 of the 5,358,157 ordinaryshares making up its equity, including 1,592,307 new shares issued through a Global Offering[1].
The admission and issue price of Amoeba shares was set at €8.30 per share. Market capitalisation was around €44.5 million on the day of listing, and the total amount raised was €13.2 million.
Fabrice Plasson, Preside of Amoeba’s Executive Board said: “We are delighted with the success of our listing, despite turmoil linked to events in Greece. And we would like to extend warm thanks to all of the new shareholders—both individuals and professionals—that have joined us today, as well as historic shareholders who also took part. Thanks, too, to the entire dynamic team at Amoeba that has rallied around with such enthusiasm. The funds raised will allow us to deploy our growth strategy for production and sales in target markets in Europe and North America.”
Eric Forest, CEO of EnterNext said: “We congratulate Amoeba on its successful market debut—proof that French and international investors are definitely on board for initiatives backed by strong equity stories, regardless of the macro-economic environment. Listing on Euronext has allowed Amoeba to raise the funds it needs to deploy a bold strategy aimed at revolutionising water treatment. As both an innovative business and an eco-business, Amoeba will be able to take full advantage of the tech industry initiatives rolled out by EnterNext.”
[1]The Global Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries.